Marc-Henri Stern Selected Research

Melanoma (Melanoma, Malignant)

7/2021	Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine.
1/2020	Uveal melanoma.
7/2019	So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020.
1/2019	Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations.
2/2017	The biological and prognostic significance of angiotropism in uveal melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc-Henri Stern Research Topics

Disease

39	Neoplasms (Cancer) 01/2021 - 09/2006
13	Breast Neoplasms (Breast Cancer) 04/2022 - 06/2007
7	Uveal melanoma 01/2021 - 07/2012
7	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2015
5	Melanoma (Melanoma, Malignant) 07/2021 - 02/2017
5	Triple Negative Breast Neoplasms 06/2021 - 05/2015
4	Circulating Neoplastic Cells 01/2019 - 03/2014
3	Carcinoma (Carcinomatosis) 01/2016 - 01/2008
2	Ovarian Neoplasms (Ovarian Cancer) 04/2020 - 12/2017
2	Microsatellite Instability 01/2020 - 10/2018
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020 - 10/2019
2	Mesothelioma 09/2017 - 02/2011
2	Leukemia 05/2007 - 08/2004
1	Neurodevelopmental Disorders 01/2022
1	Carcinogenesis 01/2021
1	Retinoblastoma (Glioblastoma, Retinal) 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Iron Overload 10/2019
1	Telangiectasis (Telangiectasia) 10/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Residual Neoplasm 01/2017
1	Adenocarcinoma 03/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016
1	Hypersensitivity (Allergy) 01/2016
1	Metaplasia 03/2015
1	Chromosomal Instability (Chromosome Stability) 09/2014
1	Hematologic Neoplasms (Hematological Malignancy) 11/2013
1	Aneuploidy (Aneuploid) 10/2013
1	Chromosome Breakage 11/2012
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 11/2012
1	Malignant Mesothelioma 02/2011
1	Hypoxia (Hypoxemia) 06/2010
1	Lymphoma (Lymphomas) 08/2009
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 02/2008
1	Infections 01/2008

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2004
10	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 06/2007
8	Circulating Tumor DNAIBA 01/2019 - 07/2012
7	Biomarkers (Surrogate Marker)IBA 01/2017 - 05/2010
4	Biological ProductsIBA 04/2020 - 05/2015
3	RNA Splicing FactorsIBA 01/2021 - 10/2019
3	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 05/2015
3	Phenobarbital (Luminal)FDA Link 02/2016 - 01/2009
3	RNA (Ribonucleic Acid)IBA 02/2016 - 06/2007
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2013
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 02/2016
2	Hormones (Hormone)IBA 11/2019 - 02/2016
2	Pharmaceutical PreparationsIBA 07/2019 - 08/2004
2	NucleotidesIBA 01/2019 - 10/2013
2	ChromatinIBA 04/2015 - 09/2006
2	Oncogene Proteins (Oncogene Protein)IBA 08/2009 - 02/2008
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2022
1	Trastuzumab (Herceptin)FDA Link 04/2022
1	Etoposide (VP 16)FDA LinkGeneric 04/2022
1	Aromatase InhibitorsIBA 01/2022
1	palbociclibIBA 01/2022
1	A-Form DNA (A-DNA)IBA 06/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Codon (Codons)IBA 01/2021
1	VaccinesIBA 04/2020
1	AntigensIBA 04/2020
1	berzosertibIBA 01/2020
1	tebentafuspIBA 01/2020
1	NSC 724998IBA 01/2020
1	indimitecanIBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	CamptothecinIBA 01/2020
1	Melphalan (Alkeran)FDA LinkGeneric 01/2020
1	Co-Repressor ProteinsIBA 01/2020
1	Topoisomerase I InhibitorsIBA 01/2020
1	IronIBA 10/2019
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Deubiquitinating EnzymesIBA 09/2017
1	UbiquitinIBA 09/2017
1	Histones (Histone)IBA 09/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2017
1	SaltsIBA 02/2016
1	PlatinumIBA 02/2016
1	HeterochromatinIBA 04/2015
1	ClaudinsIBA 03/2015
1	Fetal Proteins (Fetoprotein)IBA 09/2014
1	Immunoglobulins (Immunoglobulin)IBA 09/2014
1	Estrogen ReceptorsIBA 12/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2013
1	Indicators and Reagents (Reagents)IBA 11/2012
1	AsbestosIBA 02/2011
1	Transcription Factors (Transcription Factor)IBA 06/2010
1	Chemokine CXCL12IBA 06/2010

Therapy/Procedure

13	Therapeutics 04/2020 - 01/2008
4	Immunotherapy 01/2021 - 10/2018
2	Precision Medicine 07/2021 - 04/2015
1	Drug Therapy (Chemotherapy) 01/2020
1	Hepatectomy 01/2020
1	Neoadjuvant Therapy 01/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2013
1	Radiotherapy 10/2013